{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:33:45Z","timestamp":1760236425668,"version":"build-2065373602"},"reference-count":46,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Objective: To assess the effectiveness of three general prognostic models (APACHE II, SAPS II, and SOFA) with serum galactomannan antigen in a clinically suspected invasive aspergillosis (IA) subpopulation admitted to a respiratory medicine ICU and to identify azole-resistant Aspergillus fumigatus (ARAF) cases. Methodology and Results: A total of 235 clinically suspected IA patients were prospectively enrolled and observed 30-day mortality was 29.7%. The three general models showed poor discrimination assessed by area under receiver operating characteristic (ROC) curves (AUCs, &lt;0.7) and good calibration (p = 0.92, 0.14, and 0.13 for APACHE II, SAPS II, and SOFA, respectively), evaluated using Hosmer\u2013Lemeshow goodness-of-fit tests. However, discrimination was significantly better with galactomannan values (AUC, 0.924). In-vitro antifungal testing revealed higher minimum inhibitory concentration (MIC) for 12\/34 isolates (35.3%) whereas azole resistance was noted in 40% of Aspergillus fumigatus isolates (6\/15) with two hotspot cyp51A mutations, G54R and P216L. Conclusions: Patients diagnosed with putative and probable IA (71.4% and 34.6%, respectively), had high mortality. The general prognostic model APACHE II seemed fairly accurate for this subpopulation. However, the use of local GM cut-offs calculated for mortality, may help the intensivists in prompt initiation or change of therapy for better outcome of patients. In addition, the high MICs highlight the need of antifungal surveillance to know the local resistance rate which might aid in patient treatment.<\/jats:p>","DOI":"10.3390\/jof7110991","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T21:00:50Z","timestamp":1637528450000},"page":"991","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Scores and Azole-Resistant Aspergillus fumigatus in Invasive Aspergillosis from an Indian Respiratory Medicine ICU (ICU Patients with IA Suspicion)"],"prefix":"10.3390","volume":"7","author":[{"given":"Yubhisha","family":"Dabas","sequence":"first","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences (AIIMS), New Delhi 110029, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anant","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine and Sleep Disorders, All India Institute of Medical Sciences (AIIMS), New Delhi 110029, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Immaculata","family":"Xess","sequence":"additional","affiliation":[{"name":"Department of Microbiology, All India Institute of Medical Sciences (AIIMS), New Delhi 110029, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13054-014-0722-7","article-title":"Epidemiology of invasive aspergillosis in critically ill patients: Clinical presentation, underlying conditions, and outcomes","volume":"19","author":"Taccone","year":"2015","journal-title":"Crit. Care"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jinf.2012.07.006","article-title":"Clinical features of invasive pulmonary aspergillosis vs. colonization in COPD patients distributed by GOLD stage","volume":"65","author":"Barberan","year":"2012","journal-title":"J. Infect."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","article-title":"Clinical risk factors for invasive aspergillosis","volume":"49","author":"Baddley","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jhin.2004.01.006","article-title":"Invasive aspergillosis in critically ill patients: Attributable mortality and excesses in length of ICU stay and ventilator dependence","volume":"56","author":"Vandewoude","year":"2004","journal-title":"J. Hosp. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","article-title":"Invasive aspergillosis in critically ill patients: Analysis of risk factors for acquisition and mortality","volume":"59","author":"Vandewoude","year":"2004","journal-title":"Acta Clin. Belg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000088708","article-title":"Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia","volume":"73","author":"Gursel","year":"2006","journal-title":"Respiration"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: Clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21","author":"Verweij","year":"2015","journal-title":"Drug Resist. Updates"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_11","unstructured":"Wayne, P., and Clinical and Laboratory Standards Institute (2008). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Clinical and Laboratory Standards Institute. CLSI Document M38-A2."},{"key":"ref_12","unstructured":"Arendrup, M.C., Guinea, J., Cuenca-Estrella, M., Meletiadis, J., Mouton, J.W., Lagrou, K., Howard, S.J., and Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2015). Method for the Determination of Broth Dilution Minimum Inhibitory Concentrations of Antifungal Agents for Conidia Forming Moulds, Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST Definitive Document E. DEF 7.3."},{"key":"ref_13","unstructured":"CLSI (2018). Epidemiological Cutoff Values for Antifungal Susceptibility Testing, Clinical and Laboratory Standards Institute. [2nd ed.]. CLSI Supplement M59."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E248","DOI":"10.1111\/j.1469-0691.2012.03890.x","article-title":"EUCAST technical note on Aspergillus and amphotericin B, itraconazole, and posaconazole","volume":"18","author":"Arendrup","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_15","unstructured":"European Committee on Antimicrobial Susceptibility Testing (2021, October 11). Antifungal agents\u2014Breakpoint Tables for Interpretation of MICs, Version 8.1. Available online: http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/AFST\/Clinical_breakpoints\/Antifungal_breakpoints_v_8.1_March_2017.pdf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1128\/AAC.00156-08","article-title":"Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus","volume":"52","author":"Mellado","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/dkh507","article-title":"Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma","volume":"55","author":"Chen","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0897190010388906","article-title":"Infectious diseases in the critically ill patients","volume":"24","author":"Martin","year":"2011","journal-title":"J. Pharm. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4103\/2141-9248.113669","article-title":"Fungal infections in intensive care unit: Challenges in diagnosis and management","volume":"3","author":"Bajwa","year":"2013","journal-title":"Ann. Med. Health Sci. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13054-014-0458-4","article-title":"How to manage aspergillosis in non-neutropenic intensive care unit patients","volume":"18","author":"Bassetti","year":"2014","journal-title":"Crit. Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00134-011-2344-8","article-title":"Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis","volume":"37","author":"Burghi","year":"2011","journal-title":"Intensive Care Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: The SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5603\/AIT.2014.0027","article-title":"Prognostic value of serum galactomannan in mixed ICU patients: A retrospective observational study","volume":"47","author":"Teering","year":"2014","journal-title":"Anaesthesiol. Intensive Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13693786.2010.521523","article-title":"Value of consecutive galactomannan determinations for the diagnosis and prognosis of invasive pulmonary aspergillosis in critically ill chronic obstructive pulmonary disease","volume":"49","author":"He","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1080\/13693780600919262","article-title":"Aspergillosis in the ICU\u2014The new 21st century problem?","volume":"44","author":"Vandewoude","year":"2006","journal-title":"Med. Mycol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Vincent, J.L. (2007). The changing prognostic determinants in the critically ill patient. 2007 Yearbook of Intensive care and Emergency Medicine, Springer.","DOI":"10.1007\/978-0-387-49518-7"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/cc8204","article-title":"Clinical review: Scoring systems in the critically ill","volume":"14","author":"Vincent","year":"2010","journal-title":"Crit. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.4037\/ajcc2011763","article-title":"General prognostic scores in outcome prediction for cancer patients admitted to the intensive care unit","volume":"20","author":"Kopterides","year":"2011","journal-title":"Am. J. Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ejcdt.2015.05.012","article-title":"Comparison of the mortality prediction of different ICU scoring systems (APACHE II and III, SAPS II, and SOFA) in a single-center ICU subpopulation with acute respiratory distress syndrome","volume":"64","author":"Saleh","year":"2015","journal-title":"Egypt. J. Chest. Dis. Tuberc."},{"key":"ref_31","first-page":"329","article-title":"Prognostic value of different scoring models in patients with multiple organ dysfunction syndrome associated with acute COPD exacerbation","volume":"7","author":"Xiao","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.3109\/13693786.2010.508469","article-title":"Acquired antifungal drug resistance in Aspergillus fumigatus: Epidemiology and detection","volume":"49","author":"Howard","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in Aspergillus fumigatus associated with treatment failure","volume":"15","author":"Howard","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Snelders, E., Van Der Lee, H.A.L., Kuijpers, J., Rijs, A.J.M.M., Varga, J., Samson, R.A., Mellado, E., Donders, A.R.T., Melchers, W., and Verweij, P.E. (2008). Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med., 5.","DOI":"10.4016\/8254.01"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/jinf.2000.0747","article-title":"Antifungal drug resistance in Aspergillus","volume":"41","author":"Moore","year":"2000","journal-title":"J. Infect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e02539-20","DOI":"10.1128\/AEM.02539-20","article-title":"Aspergillus fumigatus cross-resistance between clinical and demethylase inhibitor azole drugs","volume":"87","author":"Lucio","year":"2021","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fmicb.2015.00428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","author":"Chowdhary","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jac\/dkr443","article-title":"Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR\/L98H mutations in the cyp51A gene in India","volume":"67","author":"Chowdhary","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Chowdhary, A., Kathuria, S., Xu, J., Sharma, C., Sundar, G., Singh, P.K., Gaur, S.N., Hagen, F., Klaassen, C.H., and Meis, J.F. (2012). Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR34\/L98H mutations in the cyp51A gene in India. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052871"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/dkt397","article-title":"Azole-resistant Aspergillus fumigatus with the environmental TR46\/Y121F\/T289A mutation in India","volume":"69","author":"Chowdhary","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e02264-17","DOI":"10.1128\/AAC.02264-17","article-title":"Emergence of azole-resistant Aspergillus fumigatus from immunocompromised hosts in India","volume":"62","author":"Dabas","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/JCM.00535-08","article-title":"In Vitro Survey of Triazole Cross-Resistance among More than 700 Clinical Isolates of Aspergillus Species","volume":"46","author":"Pfaller","year":"2008","journal-title":"J. Clin. Microbiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Baddley","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_44","first-page":"2706","article-title":"In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin","volume":"123","author":"Shi","year":"2010","journal-title":"Chin. Med. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jac\/dku410","article-title":"Concomitant occurrence of itraconazole-resistant and -susceptible strains of Aspergillus fumigatus in routine cultures","volume":"70","author":"Ahmad","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/AAC.05394-11","article-title":"Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/11\/991\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:10Z","timestamp":1760167990000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/7\/11\/991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["jof7110991"],"URL":"https:\/\/doi.org\/10.3390\/jof7110991","relation":{},"ISSN":["2309-608X"],"issn-type":[{"type":"electronic","value":"2309-608X"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}